(4S,7S,10S,13S,16S)-4-(4-aminobutyl)-7-sec-butyl-18,18-difluoro-10-((R)-1-hydroxyethyl)-13,16-dimethyl-2,5,8,11,14,17,19-heptaoxo-3,6,9,12,15,20-hexaazadocosan-22-oic acid

ID: ALA3310712

PubChem CID: 118706730

Max Phase: Preclinical

Molecular Formula: C28H47F2N7O10

Molecular Weight: 679.72

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)C(F)(F)C(=O)NCC(=O)O)[C@@H](C)O

Standard InChI:  InChI=1S/C28H47F2N7O10/c1-7-13(2)20(36-24(44)18(35-17(6)39)10-8-9-11-31)25(45)37-21(16(5)38)26(46)34-15(4)23(43)33-14(3)22(42)28(29,30)27(47)32-12-19(40)41/h13-16,18,20-21,38H,7-12,31H2,1-6H3,(H,32,47)(H,33,43)(H,34,46)(H,35,39)(H,36,44)(H,37,45)(H,40,41)/t13-,14-,15-,16+,18-,20-,21-/m0/s1

Standard InChI Key:  CFPLHMNEXLZOCF-FOXYBHETSA-N

Molfile:  

     RDKit          2D

 47 46  0  0  0  0  0  0  0  0999 V2000
   16.8553   -7.1271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8553   -6.3021    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.5730   -7.5395    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2830   -7.5375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9906   -7.1250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7086   -8.3603    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7086   -7.5353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9906   -6.2978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7086   -5.8853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7086   -5.0603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4224   -4.6479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4224   -3.8230    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4224   -7.1250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1339   -7.5353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8519   -6.2978    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.8519   -7.1228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1339   -8.3603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8519   -8.7728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4224   -8.7728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4224   -9.5978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5636   -7.5353    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.2775   -7.1228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9953   -8.3603    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.9953   -7.5353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2775   -6.2978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9953   -5.8853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7092   -7.1228    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.4207   -7.5353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1387   -6.2978    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.4207   -8.3603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1387   -7.1228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8526   -7.5353    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.5642   -7.1228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2822   -8.3603    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.5642   -6.2978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2822   -7.5353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9958   -7.1228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7076   -7.5353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7076   -8.3603    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.4255   -7.1228    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5662   -7.1268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8514   -7.5411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5641   -6.3020    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5660   -5.8849    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.5794   -6.4036    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   14.4044   -6.4036    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   16.1391   -7.5369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  1  0
  1  2  2  0
  7 13  1  0
 16 21  1  0
 24 27  1  0
 31 32  1  0
 36 37  1  0
  4  5  1  0
  5  7  1  0
  7  6  2  0
  5  8  1  1
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 13 14  1  0
 14 16  1  6
 16 15  2  0
 14 17  1  0
 17 18  1  1
 17 19  1  0
 19 20  1  0
 21 22  1  0
 22 24  1  1
 24 23  2  0
 22 25  1  0
 25 26  1  0
 27 28  1  0
 28 31  1  0
 31 29  2  0
 28 30  1  6
 32 33  1  0
 33 36  1  0
 36 34  2  0
 33 35  1  1
 37 38  1  0
 38 40  1  0
 38 39  2  0
  4 41  1  0
 41 42  1  0
 41 43  2  0
 25 44  1  6
 37 45  1  0
 37 46  1  0
 40 47  1  0
 47  1  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3310712

    ---

Associated Targets(non-human)

SUB1 Subtilisin-like protease (110 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 679.72Molecular Weight (Monoisotopic): 679.3352AlogP: -2.57#Rotatable Bonds: 21
Polar Surface Area: 275.22Molecular Species: ZWITTERIONHBA: 10HBD: 9
#RO5 Violations: 2HBA (Lipinski): 17HBD (Lipinski): 10#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.56CX Basic pKa: 10.18CX LogP: -4.71CX LogD: -4.72
Aromatic Rings: Heavy Atoms: 47QED Weighted: 0.04Np Likeness Score: 0.15

References

1. Giovani S, Penzo M, Brogi S, Brindisi M, Gemma S, Novellino E, Savini L, Blackman MJ, Campiani G, Butini S..  (2014)  Rational design of the first difluorostatone-based PfSUB1 inhibitors.,  24  (15): [PMID:24909083] [10.1016/j.bmcl.2014.05.044]
2. Lidumniece E, Withers-Martinez C, Hackett F, Blackman MJ, Jirgensons A..  (2022)  Subtilisin-like Serine Protease 1 (SUB1) as an Emerging Antimalarial Drug Target: Current Achievements in Inhibitor Discovery.,  65  (19.0): [PMID:36137276] [10.1021/acs.jmedchem.2c01093]

Source